{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:25:06Z","timestamp":1759580706454},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.bone.2004.03.028","type":"journal-article","created":{"date-parts":[[2004,6,21]],"date-time":"2004-06-21T19:51:08Z","timestamp":1087847468000},"page":"153-161","source":"Crossref","is-referenced-by-count":17,"title":["A new selective estrogen receptor modulator HMR-3339 fully corrects bone alterations induced by ovariectomy in adult rats"],"prefix":"10.1016","volume":"35","author":[{"given":"P","family":"Ammann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Bourrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Cl\u00e9ment-Lacroix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2004.03.028_BIB1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s001980050242","article-title":"The new selective estrogen receptor modulator MDL 103,323 increases bone mineral density and bone strength in adult ovariectomized rats fed an isocaloric low-protein diet","volume":"10","author":"Ammann","year":"1999","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2004.03.028_BIB2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1359\/jbmr.2002.17.7.1264","article-title":"Dietary essential amino acid supplements increase bone strength by influencing bone mass and bone microarchitecture in ovariectomized adult rats fed an isocaloric low-protein diet","volume":"17","author":"Ammann","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.03.028_BIB3","series-title":"Osteoporosis: diagnosis and management","first-page":"257","article-title":"Preclinical evaluation of new therapeutic agents for osteoporosis","author":"Ammann","year":"1998"},{"key":"10.1016\/j.bone.2004.03.028_BIB4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01622738","article-title":"Bone density and shape as determinants of bone strength in IGF-I and\/or pamidronate-treated ovariectomized rats","volume":"6","author":"Ammann","year":"1996","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2004.03.028_BIB5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jbmr.5650070310","article-title":"Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometry","volume":"7","author":"Ammann","year":"1992","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.03.028_BIB6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s002239900344","article-title":"Effect of estrogen deficiency on cancellous and cortical bone structure and strength of the femoral neck in rats","volume":"61","author":"Bagi","year":"1997","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2004.03.028_BIB7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/(SICI)1097-0185(199608)245:4<633::AID-AR3>3.0.CO;2-P","article-title":"Histo-anatomy of the proximal femur in rats: impact of ovariectomy on bone mass, structure, and stiffness","volume":"245","author":"Bagi","year":"1996","journal-title":"Anat. Rec."},{"key":"10.1016\/j.bone.2004.03.028_BIB8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1172\/JCI116985","article-title":"Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats","volume":"93","author":"Black","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2004.03.028_BIB9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S8756-3282(01)00661-5","article-title":"Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats","volume":"30","author":"Bourrin","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.03.028_BIB10","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/jbmr.5650101118","article-title":"Effect of physical training on bone adaptation in three zones of the rat tibia","volume":"10","author":"Bourrin","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.03.028_BIB11","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/jbmr.5650100816","article-title":"Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study","volume":"10","author":"Chen","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.03.028_BIB12","doi-asserted-by":"crossref","first-page":"175S","DOI":"10.1016\/8756-3282(95)00290-T","article-title":"Droloxifene inhibits cortical bone turnover associated with estrogen deficiency in rats","volume":"17","author":"Chen","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.03.028_BIB13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01880410","article-title":"Estrogens, bone loss and preservation","volume":"1","author":"Christiansen","year":"1991","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2004.03.028_BIB14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/er.2001-4002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2004.03.028_BIB15","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2004.03.028_BIB16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S8756-3282(03)00241-2","article-title":"Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial","volume":"33","author":"Delmas","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.03.028_BIB17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jbmr.5650110615","article-title":"A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women","volume":"11","author":"Draper","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.03.028_BIB18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2004.03.028_BIB19","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/en.134.5.2283","article-title":"The effects of raloxifene on tibia histomorphometry in ovariectomized rats","volume":"134","author":"Evans","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2004.03.028_BIB20","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/0959-8049(93)90003-X","article-title":"Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy","volume":"29A","author":"Friedl","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bone.2004.03.028_BIB21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/8756-3282(96)00085-3","article-title":"Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate","volume":"18","author":"Frolik","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.03.028_BIB22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9343(99)80251-4","article-title":"The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women","volume":"99","author":"Grey","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2004.03.028_BIB23","first-page":"1727","article-title":"In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen","volume":"53","author":"Huynh","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2004.03.028_BIB24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/8756-3282(91)90022-B","article-title":"Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone","volume":"12","author":"Jorgensen","year":"1991","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.03.028_BIB25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","article-title":"The ovariectomized rat model of postmenopausal bone loss","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner."},{"key":"10.1016\/j.bone.2004.03.028_BIB26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0169-6009(91)90002-H","article-title":"A comparative study of the actions of tamoxifen, estrogen and progesterone in the ovariectomized rat","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner."},{"key":"10.1016\/j.bone.2004.03.028_BIB27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/8756-3282(95)00346-2","article-title":"Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats","volume":"17","author":"Ke","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.03.028_BIB28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1359\/jbmr.2001.16.4.765","article-title":"Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats","volume":"16","author":"Ke","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.03.028_BIB29","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1210\/en.136.6.2435","article-title":"Droloxifene, a new estrogen antagonist\/agonist, prevents bone loss in ovariectomized rats","volume":"136","author":"Ke","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2004.03.028_BIB30","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1359\/jbmr.2002.17.12.2256","article-title":"Long-term dosing of arzoxifene lowers cholesterol, reduces bone turnover, and preserves bone quality in ovariectomized rats","volume":"17","author":"Ma","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.03.028_BIB31","series-title":"Bone histomorphometry: techniques and interpretation","first-page":"53","article-title":"Stereologic basis of bone histomorphometry: theory of quantitative microscopy and reconstruction of the third dimension","author":"Parfitt","year":"1983"},{"key":"10.1016\/j.bone.2004.03.028_BIB32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.03.028_BIB33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","article-title":"Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women","volume":"14","author":"Powles","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2004.03.028_BIB34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective estrogen-receptor modulators\u2014mechanisms of action and application to clinical practice","volume":"348","author":"Riggs","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2004.03.028_BIB35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jbmr.5650090517","article-title":"Dual-energy X-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats","volume":"9","author":"Sato","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.03.028_BIB36","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1210\/en.135.5.2001","article-title":"Raloxifene preserves bone strength and bone mass in ovariectomized rats","volume":"135","author":"Turner","year":"1994","journal-title":"Endocrinology"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204001541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204001541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T20:53:00Z","timestamp":1549486380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328204001541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S8756328204001541"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2004.03.028","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}